Researchers have discovered that a DNA modification called 5-formylcytosine (5fC) functions as an activating epigenetic switch that kick-starts genes in early embryonic development. This finding ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific activation site on the Dicer enzyme that changes its shape and function, influencing cell division and ...

DNA is often seen as the blueprint of life—carrying the code to govern the development and traits of an organism—but “there are things beyond the DNA sequence,” says Xiaoqi Feng, a plant geneticist at ...

A molecular model showing three of the main epigenetic modifications of DNA (orange) and histones (dark blue) [JUAN GAERTNER/Science Photo Library/Getty Images] Post-translational modifications (PTMs) ...

Scientists of the German Center for Diabetes Research (DZD) led by the German Institute of Human Nutrition (DIfE) have shown in a mouse model that the epigenetic modification of the Igfbp2 gene ...

In 2018, when the study of potentially modifiable genetic markers for sleep apnea was emerging, a group of researchers from Mexico published a study titled, “Dad’s snoring may have left molecular ...

Epigenetics is rewriting what we know about how our genes work, adapt, and sometimes fail. From chemical tags that switch genes on or off to RNA molecules that fine-tune expression, scientists are ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...

Add Yahoo as a preferred source to see more of our stories on Google. Marijuana And Joint On Wooden Surface Using cannabis may cause changes in the human body's epigenome, a study of over 1,000 adults ...

The team of Professor Christof Niehrs at the Institute of Molecular Biology (IMB) in Mainz, Germany, has discovered that a DNA modification called 5-formylcytosine (5fC) functions as an activating ...